A Randomised study of Docetaxol with Carboplatin vs Mitomycin, Vinblastine, Cisplatin (MVP) or Mitomycin, Ifosfamide and Cisplatin (MIC) in Inoperable Advanced Non Small Cell Lung Cancer

Trial Profile

A Randomised study of Docetaxol with Carboplatin vs Mitomycin, Vinblastine, Cisplatin (MVP) or Mitomycin, Ifosfamide and Cisplatin (MIC) in Inoperable Advanced Non Small Cell Lung Cancer

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Docetaxel (Primary) ; Carboplatin; Cisplatin; Ifosfamide; Mitomycin; Vinblastine
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms DOCMIC
  • Most Recent Events

    • 12 Feb 2016 Status changed from active, no longer recruiting to completed, according to United Kingdom Clinical Research Network record.
    • 08 Dec 2015 Accrual to date is 100% according to United Kingdom Clinical Research Network record.
    • 01 Aug 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top